Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Aripiprazole Otsuka 400 mg powder and solvent for prolonged-release suspension for injection in pre-filled syringe

Active Ingredient:
aripiprazole
Company:  
Otsuka Pharmaceuticals (UK) Ltd See contact details
ATC code: 
N05AX12
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) User Manual
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 24 Mar 2026
{pdf} View or print the patient leaflet as PDF
Otsuka Pharmaceuticals (UK) Ltd
Company image
Address
2 Windsor Dials, Arthur Road, Windsor, SL4 1RS, UK
Telephone
+44 (0)20 3747 5300
Fax
+44 (0)20 8848 0529
Medical Information e-mail
[email protected]
WWW
http://www.otsuka-europe.com